Recent data reveals that retatrutide, a novel medication, might represent a significant improvement in body reduction . This treatment combines the properties of a GLP-1 analog and a GIP receptor , seemingly offering a greater benefit than existing approaches . Clinical research have demonstrated promising results , including significant declines i